The Government Circuit: Driving Resiliency and Economic Security on Both Sides of the Atlantic
American Made Advocacy: Taking the Fight to Capitol Hill
Defense Speak Interpreted: SWaPing Nanosatellites for Defense SystemsCicor Acquires Evolution Medtec Srl, Strengthens Engineering Capabilities in Medtech Sector
February 28, 2024 | Cicor Technologies Ltd.Estimated reading time: 1 minute
The Cicor Group has acquired 100% of the shares of the Romanian engineering company Evolution Medtec Srl and is further expanding its engineering capabilities in the medical technology sector.
Evolution Medtec is a provider of comprehensive engineering services with a strong focus on medical and paramedical applications. The company has been active in the development and prototyping of medtech applications for 20 years and currently employs 25 people in Bucharest, Romania. The FDA registered site is ISO 13485 certified. In the last fiscal year, Evolution Medtec generated sales in the lower single-digit million Euro range with an EBITDA margin comparable to the Cicor Group. Evolution Medtec's longstanding customers are medium and large medical device and industrial companies in Europe, the UK, and the US.
Cicor is one of Europe's fastest-growing developers and manufacturers of high-reliability electronics for the medical, industrial, aerospace and defence markets. With the acquisition of Evolution Medtec, Cicor further strengthens its engineering expertise and capacity in the strategically important medical technology market. Cicor will continue to provide first-class development services at Evolution Medtec's existing site under the leadership of the existing management team.
With the acquisition of Evolution Medtec and STS Defence (transaction completed in January 2024), Cicor has created one of the strongest R&D platforms in the European EMS industry, doubling the resources to develop highly advanced electronic solutions for the medical, industrial, aerospace and defence markets.
Share on:
Suggested Items
Global Flexible Substrate Market Size To Worth USD 2520.19 Million by 2033; CAGR Of 14.50%
07/16/2024 | Globe NewswireThe Global Flexible Substrate Market Size is to Grow from USD 650.62 Million in 2023 to USD 2520.19 Million by 2033, at a Compound Annual Growth Rate (CAGR) of 14.50% during the projected period.
Presto Engineering Achieves Medical Device ISO 13485 Quality Management Certification
07/12/2024 | Presto EngineeringThe certification covers Presto’s Denmark hub to ensure that its ASIC design and production services consistently meet medical device customer expectations and relevant regulatory requirements.
Beck Automation AG Opens New Facility in Dällikon with a Focus on Medical Automation
07/09/2024 | Beck Automation AGBeck Automation AG is pleased to announce the opening of its new facility in Dällikon. This move highlights the ongoing growth and the commitment to providing top-notch service and innovative solutions to the customers of Beck Automation.
Exciting Times Ahead For IMI
07/09/2024 | IMIIntegrated Micro-Electronics, Inc. “These are exciting times ahead of us at IMI,” said Louis Sylvester Hughes, the company’s new CEO, rallying all employees and assuring all stakeholders of the company during a recently held townhall meeting at the company’s headquarters in Laguna. Employees from the company’s offshore sites were also listening online.
UHDI Fundamentals: UHDI Applications for Medical Devices
07/03/2024 | Anaya Vardya, American Standard CircuitsUltra high-density interconnect (UHDI) technology typically refers to advanced printed circuit board (PCB) manufacturing techniques that allow for a higher density of electronic components and interconnections within a smaller area. While not directly related to medical applications on its own, UHDI technology can indirectly benefit various medical devices and equipment by enabling smaller, more compact designs with increased functionality and performance.